Saturday, August 22

● Latest

Markets Moderna added $44 billion in market value on a cancer result that has not been published Economy Washington puts 50% tariffs on $20 billion of Canadian goods, four days after pausing them Markets Everyone is talking about debasement. The bond market says inflation expectations are 2.3%Tech Nvidia is now buying the electricity supply for the customers who buy its chips Markets The sanctions land Monday, but the blockade has already cut Hormuz traffic by 60%Economy Asia's AI windfall is real, and it is not being shared evenly Crypto Ray Dalio wants gold at 10% to 15% and only 'a bit' of bitcoin. The gap matters Companies Apple cuts 200 jobs from Vision Pro and Siri, the two bets it most needed to work Markets Moderna added $44 billion in market value on a cancer result that has not been published Economy Washington puts 50% tariffs on $20 billion of Canadian goods, four days after pausing them Markets Everyone is talking about debasement. The bond market says inflation expectations are 2.3%Tech Nvidia is now buying the electricity supply for the customers who buy its chips Markets The sanctions land Monday, but the blockade has already cut Hormuz traffic by 60%Economy Asia's AI windfall is real, and it is not being shared evenly Crypto Ray Dalio wants gold at 10% to 15% and only 'a bit' of bitcoin. The gap matters Companies Apple cuts 200 jobs from Vision Pro and Siri, the two bets it most needed to work

Topic: merck

Kendall Square in Cambridge, Massachusetts, the biotechnology district where Moderna is based

Saturday, 8/22, 12:52 AM

Moderna added $44 billion in market value on a cancer result that has not been published

Moderna and Merck say their individualised mRNA vaccine met its primary and secondary endpoints in melanoma.
The shares nearly tripled, adding about $44 billion.
What the companies have not disclosed is the number of patients, the trial phase, the hazard ratio, or how long the effect lasted.

merck — news and stories on this topic

This page collects all of Boursel's coverage of merck. Follow the topic from one place: new stories appear here automatically as more is published. That way you stay on top of how the situation develops.

Looking for the bigger picture? Browse markets, the economy, companies and crypto, or head back to the front page for the day's top stories.